新型冠状病毒肺炎伴发的皮肤表现

doi:10.35541/cjd.20200509

Abstract

Abstract: 【Abstract】 COVID-19 can be accompanied by a variety of cutaneous abnormalities, which mainly include vascular lesions （chilblain-like lesions, livedo reticularis, purpura, ecchymosis, acral cyanosis, gangrene） and inflammatory lesions （diffuse erythema, morbilliform exanthem, acute urticaria, varicella-like exanthem）. Some types of skin lesions may be the first symptom or the only clinical manifestation of COVID-19.

Key words: Skin manifestations, COVID-19, Chilblains, Livedo reticularis, Purpura, Urticaria

Gao Meng, Jiang Yiqun. Cutaneous manifestations of COVID-19[J]. Chinese Journal of Dermatology, 2022, 55(10): 932-934.doi:10.35541/cjd.20200509

References ［26］

［1］	World Health Organization. WHO director⁃general′s opening remarks at the media briefing on COVID⁃19 ⁃ 11 March 2020［EB/OL］. ［2020⁃03⁃11］. https://www.who.int/dg/speeches/detail/who⁃director⁃general⁃s⁃opening⁃remarks⁃at⁃the⁃media⁃briefing⁃on⁃covid⁃19⁃⁃⁃11⁃march⁃2020.
［2］	Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 （COVID⁃19） outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention［J］. JAMA, 2020,323（13）:1239⁃1242. doi: 10.1001/jama.2020.2648.
［3］	Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China［J］. N Engl J Med, 2020,382（18）:1708⁃1720. doi: 10.1056/NEJMoa2002032.
［4］	Recalcati S. Cutaneous manifestations in COVID⁃19: a first perspective［J］. J Eur Acad Dermatol Venereol, 2020,34（5）:e212⁃e213. doi: 10.1111/jdv.16387.
［5］	Duong TA, Velter C, Rybojad M, et al. Did Whatsapp® reveal a new cutaneous COVID⁃19 manifestation?［J］. J Eur Acad Dermatol Venereol, 2020,34（8）:e348⁃e350. doi: 10.1111/jdv. 16534.
［6］	Piccolo V, Neri I, Filippeschi C, et al. Chilblain⁃like lesions during COVID⁃19 epidemic: a preliminary study on 63 patients［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:e291⁃e293. doi: 10.1111/jdv.16526.
［7］	Colonna C, Monzani NA, Rocchi A, et al. Chilblain⁃like lesions in children following suspected COVID⁃19 infection［J］. Pediatr Dermatol, 2020,37（3）:437⁃440. doi: 10.1111/pde.14210.
［8］	Kolivras A, Dehavay F, Delplace D, et al. Coronavirus （COVID⁃19） infection⁃induced chilblains: a case report with histopathologic findings［J］. JAAD Case Rep, 2020,6（6）:489⁃492. doi: 10.1016/j.jdcr.2020.04.011.
［9］	Alramthan A, Aldaraji W. Two cases of COVID⁃19 presenting with a clinical picture resembling chilblains: first report from the Middle East［J］. Clin Exp Dermatol, 2020,45（6）:746⁃748. doi: 10.1111/ced.14243.
［10］	Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID⁃19 infection: a report of five cases［J］. Transl Res, 2020,220:1⁃13. doi: 10.1016/j.trsl.2020.04.007.
［11］	Manalo IF, Smith MK, Cheeley J, et al. A dermatologic manifestation of COVID⁃19: transient livedo reticularis［J］. J Am Acad Dermatol, 2020,83（2）:700. doi: 10.1016/j.jaad.2020.04.018.
［12］	Zulfiqar AA, Lorenzo⁃Villalba N, Hassler P, et al. Immune thrombocytopenic purpura in a patient with Covid⁃19［J］. N Engl J Med, 2020,382（18）:e43. doi: 10.1056/NEJMc2010472.
［13］	张炎, 曹玮, 肖盟, 等. 合并肢端缺血表现的危重型新型冠状病毒肺炎七例临床分析［J］. 中华血液学杂志, 2020,41（4）:302⁃307. doi: 10.3760/cma.j.issn.0253⁃2727.2020.0006.
［14］	Gianotti R, Veraldi S, Recalcati S, et al. Cutaneous clinico⁃pathological findings in three COVID⁃19⁃positive patients observed in the Metropolitan Area of Milan, Italy［J］. Acta Derm Venereol, 2020,100（8）:adv00124. doi: 10.2340/00015555⁃3490.
［15］	Hunt M, Koziatek C. A case of COVID⁃19 pneumonia in a young male with full body rash as a presenting symptom［J］. Clin Pract Cases Emerg Med, 2020,4（2）:219⁃221. doi: 10.5811/cpcem.2020. 3.47349.
［16］	Avellana Moreno R, Estela Villa LM, Avellana Moreno V, et al. Cutaneous manifestation of COVID⁃19 in images: a case report［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:e307⁃e309. doi: 10.1111/jdv.16531.
［17］	Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID⁃19: report of three cases and a review of literature［J］. J Dermatol Sci, 2020,98（2）:75⁃81. doi: 10.1016/j.jdermsci.2020. 04.011.
［18］	杨婷, 石年, 田黎明, 等. 伴荨麻疹样皮疹的新型冠状病毒肺炎一例［J］. 中华皮肤科杂志, 2020,53（8）:646⁃648. doi: 10. 35541/cjd.20200216.
［19］	Henry D, Ackerman M, Sancelme E, et al. Urticarial eruption in COVID⁃19 infection［J］. J Eur Acad Dermatol Venereol, 2020,34（6）:e244⁃244e245. doi: 10.1111/jdv.16472.
［20］	van Damme C, Berlingin E, Saussez S, et al. Acute urticaria with pyrexia as the first manifestations of a COVID⁃19 infection［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:e300⁃e301. doi: 10. 1111/jdv.16523.
［21］	Lu S, Lin J, Zhang Z, et al. Alert for non⁃respiratory symptoms of Coronavirus disease 2019 （COVID⁃19） patients in epidemic period: a case report of familial cluster with three asymptomatic COVID⁃19 patients［J］. J Med Virol, 2021,93（1）:518⁃521. doi: 10.1002/jmv. 25776.
［22］	Marzano AV, Genovese G, Fabbrocini G, et al. Varicella⁃like exanthem as a specific COVID⁃19⁃associated skin manifestation: multicenter case series of 22 patients［J］. J Am Acad Dermatol, 2020,83（1）:280⁃285. doi: 10.1016/j.jaad.2020.04.044.
［23］	Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID⁃19 infection［J］. J Eur Acad Dermatol Venereol, 2020,doi: 10.1111/jdv.16579.
［24］	Joob B, Wiwanitkit V. COVID⁃19 can present with a rash and be mistaken for dengue［J］. J Am Acad Dermatol, 2020,82（5）:e177. doi: 10.1016/j.jaad.2020.03.036.
［25］	Gianotti R, Zerbi P, Dodiuk⁃Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID⁃19 infection in the Northern part of Italy［J］. J Dermatol Sci, 2020,98（2）:141⁃143. doi: 10.1016/j.jdermsci.2020. 04.007.
［26］	姚小红, 李廷源, 何志承, 等. 新型冠状病毒肺炎（COVID⁃19）三例遗体多部位穿刺组织病理学研究［J］. 中华病理学杂志, 2020,49（5）:411⁃417. doi: 10.3760/cma.j.cn112151⁃20200312⁃00193.

[1]	Gu Ankang, Zhang Yu, Ma Faku, Kong Xiangjun, Zhang Litao. Clinicopathological analysis of 56 cases of swimming pool granuloma [J]. Chinese Journal of Dermatology, 2022, 55(9): 795-798.
[2]	Lu Nan, Tan Xingyou, Liu Xiang, Niu Lili, Yao Shulan. Association of single nucleotide polymorphisms in microRNAs with the risk of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2022, 55(9): 806-809.
[3]	Yang Zhou, Xu Zhe, Wang Zhaoyang, Chen Yunliu, Ma Lin. TP63 gene mutation analysis in a case of ankyloblepharon-ectodermal defects-cleft lip/palate syndrome [J]. Chinese Journal of Dermatology, 2022, 55(8): 696-699.
[4]	Wang Yuan, Li Zhiliang, Li Suo, Jing Ke, Sun Chao, Liang Guirong, Zhang Hanmei, Feng Suying. Clinical and immunoserological features of 7 cases of anti-p200 pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(7): 557-561.
[5]	Zhang Shimin, Hu Yunyun, Zhao Xiaoqing, Du Lianjun, Cao Hua, Zheng Jie. Application of imaging techniques in diagnosis and severity assessment of dermatomyositis [J]. Chinese Journal of Dermatology, 2022, 55(7): 637-640.
[6]	Centre for Urticaria Research, Chinese Society of Dermatology. Guidelines for education of patients with chronic urticaria [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220305-e20220305.
[7]	Shen Chen, Chen Junjun, Yang Ji, Hu Dongyan, Xin Chongmei, Li Ming. Clinical features and classification of 180 patients with morphea [J]. Chinese Journal of Dermatology, 2022, 55(4): 308-315.
[8]	Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250.
[9]	Han Xiaofeng, Sun Juan, Qiu Lei, Wei Li, Ma Lin. Analysis of clinical and pathological features of 29 cases of perforating pilomatricoma [J]. Chinese Journal of Dermatology, 2022, 55(3): 196-199.
[10]	Li Jiafeng, Liu Ling, Liu Fang. Clinicopathological analysis of eight cases of follicular porokeratosis [J]. Chinese Journal of Dermatology, 2022, 55(10): 854-857.
[11]	Wang Anqi, Su Jing, Zhang Long, Jiang Yanan, Zhang Juan, Li Zailing, Wang Wenhui. Analysis of skin manifestations in 50 children with inflammatory bowel disease [J]. Chinese Journal of Dermatology, 2022, 55(10): 895-899.
[12]	Zhang Ying, Gan Lu, Li Siqi, Li Yan, Song Hao, Shao Xuebao, Zhang Wei, Xu Xiulian, Jiang Yiqun, Zeng Xuesi, Chen Hao, Sun Jianfang. Clinicopathological and immunophenotypic analysis of 24 cases of transformed mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(1): 20-26.
[13]	Jia Tao, Song Xiangjin, Geng Songmei. Autoinflammatory dermatosis [J]. Chinese Journal of Dermatology, 2022, 0(1): 20201253-e20201253.
[14]	Zou Meirong, Wang Sheng. Cutaneous immune-related adverse reactions induced by immune checkpoint inhibitors [J]. Chinese Journal of Dermatology, 2022, 0(1): 20201221-e20201221.
[15]	Yu Miao, Song Xiaoting, Liu Bo, Liao Shuanglu, Luan Tingting, Zhao Zuotao. Mechanism of Immunology，Clinical Features and Implications of Autologous Serum Skin Test [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210377-e20210377.

Cutaneous manifestations of COVID-19

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 15

Metrics

Comments

Recommended 10